UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054622
Receipt number R000062414
Scientific Title Dynamic layer-by-layer assessment of the tear film
Date of disclosure of the study information 2024/07/10
Last modified on 2024/10/25 19:21:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Dynamic layer-by-layer assessment of the tear film

Acronym

TF imaging

Scientific Title

Dynamic layer-by-layer assessment of the tear film

Scientific Title:Acronym

TF imaging

Region

Japan


Condition

Condition

Dry eye, dry eye suspect, and eyes with abrnomal tear film/ocular surface

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate tear dynamics in dry eyes and eyes with abnormal tear film using a device that can simultaneously observe the thickness of the aqueous and lipid layers of the tear fim noninvasively

Basic objectives2

Others

Basic objectives -Others

This study is not intended to confirm the efficacy or safety of the devices. The purpose is to conduct research to further pursue the relationship between the optical properties of tear fluid and visual function by performing a comprehensive evaluation including temporal changes in the tear film, which at this stage can only be done using separate devices, similar to conventional commercial devices.

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Temporal changes in lipid layer and aqueous layer thickness, dynamic mapping of the lipid layer

Key secondary outcomes

Tear breakup time and sybjective symptoms, based on diagnostic criteria of dry eye (Asia Dry Eye Society)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with dry eye or suspected dry eye based on the 2016 dry eye diagnostic criteria, Patients with abrnomal tear film/ocular surface requiring differential diagnosis including dry eye, Patients who are 20 years of age or older at the time of obtaining consent and who have given written consent to participate in the research

Key exclusion criteria

Patients who do not wish to be examined, Patients with poor vision and difficulty with fixation, Patients for whom the test is not reliable, Other patients deemed inappropriate by the Principal Investigator/Investigator.

Target sample size

180


Research contact person

Name of lead principal investigator

1st name Kohji
Middle name
Last name Nishida

Organization

Osaka University Graduate School of Medicine

Division name

Department of Ophthalmology

Zip code

5650871

Address

Rm. E7, 2-2 Yamadaoka, Suita, Osaka

TEL

+81-6-6879-3456

Email

knishida@ophthal.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name Shizuka
Middle name
Last name Koh

Organization

Osaka University Graduate School of Medicine

Division name

Department of Ophthalmology

Zip code

650-0044

Address

Rm. E7, 2-2 Yamadaoka, Suita, Osaka

TEL

+81-6-6879-3456

Homepage URL


Email

cizciz@gmail.com


Sponsor or person

Institute

Osaka University Graduate School of Medicine

Institute

Department

Personal name

Shizuka Koh


Funding Source

Organization

Topcon

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka University Hospital

Address

2-2 Yamadaoka, Suita, Osaka, Japan

Tel

+81-6-6210-8296

Email

rinri@hp-crc.med.osaka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 07 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2024 Year 07 Month 11 Day

Date of IRB

2024 Year 07 Month 19 Day

Anticipated trial start date

2024 Year 08 Month 01 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Normal healthy conrols are not included. Performed during a regular outpatient visit. No prior screening and no treatment intervention. Although the device used is a prototype, safety standards are equivalent to those of commercially available medical devices. The thickness of the liquid and oil layers of the lacrimal fluid layer can be measured simultaneously in a noninvasive, non-contact, quantitative manner. This study does not confirm the efficacy or safety of the device. This study is similar to a routine outpatient examination, and there are no medical procedures that will burden the patient other than time. Diagnosis, treatment, and other medical policies will not be affected by this evaluation.


Management information

Registered date

2024 Year 06 Month 10 Day

Last modified on

2024 Year 10 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062414